Intracranial Stenting Doesn’t Make The Cut In NIH Study
This article was originally published in The Gray Sheet
Executive Summary
Intracranial stenting should not be a first-line treatment in most patients with narrowed brain arteries and a recent neurological event, researchers concluded in a recent study. But the data should not be viewed as a nail in the coffin to future development of intracranial stents, investigators stressed.
You may also be interested in...
NICE In Brief
U.K. institute says DySIS Medical's digital video colposcope is a clinically effective and cost-effective option for detecting cervical cancer. But it calls for more research on stenting to prevent stroke. More NICE briefs.
Regulatory News In Brief
Lawmakers urge OMB to release unique device identifier rule. FDA selects device firms for early feasibility study pilot. More regulatory briefs.
Regulatory News In Brief
Group urges FDA to pull Stryker’s Wingspan stent from the market, among other regulatory updates.